SEZ6L2/BSRP-A Antibody [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # AF4916F
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human, Mouse
Applications
Immunohistochemistry, Western Blot
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Polyclonal Sheep IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse SEZ6L2/BSRP-A
Leu28-Ser837
Accession # Q4V9Z5
Leu28-Ser837
Accession # Q4V9Z5
Specificity
Detects human and mouse SEZ6L2/BSRP-A in direct ELISAs and Western blots. In direct ELISAs and Western blots, less than 5% cross-reactivity with recombinant mouse (rm) BSRP-B and rmBSRP-C is observed.
Clonality
Polyclonal
Host
Sheep
Isotype
IgG
Applications for SEZ6L2/BSRP-A Antibody [FITC]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: SEZ6L2/BSRP-A
Long Name
Seizure Related 6 Homolog-Like 2/Brain-specific Receptor-like Protein-A
Alternate Names
BSRP-A, BSRPA, PSK-1
Gene Symbol
SEZ6L2
Additional SEZ6L2/BSRP-A Products
Product Documents for SEZ6L2/BSRP-A Antibody [FITC]
Product Specific Notices for SEZ6L2/BSRP-A Antibody [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...